Lv3
210 积分 2023-09-18 加入
Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study
8天前
已完结
Efficacy and safety of a selective URAT1 inhibitor SHR4640 in Chinese subjects with hyperuricaemia: a randomized controlled phase II study
8天前
已完结
Gender Difference in the Association of Hyperuricemia with Chronic Kidney Disease in Southern China
11天前
已完结
Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study
14天前
已完结
POS0935 AR882, A SELECTIVE URAT1 INHIBITOR, EXHIBITS NO DRUG-DRUG INTERACTIONS WITH KEY RENAL, HEPATIC, AND GI TRANSPORTERS
26天前
已关闭
Deuterium in drug discovery: progress, opportunities and challenges
29天前
已完结
Treatment Target and Followup Measures for Patients with Gout: A Systematic Literature Review
1个月前
已完结
Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout
1个月前
已完结
Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout
1个月前
已完结
Treatment target and followup measures for patients with gout: a systematic literature review
1个月前
已完结